Pharmacological interventions for acute pancreatitis

Review of 78 trials (n=7366) noted very low-quality evidence suggesting that none of the pharmacological treatments studied decrease short-term mortality in people with acute pancreatitis.

The treatments assessed in these  trials included antibiotics, antioxidants, aprotinin, atropine, calcitonin, cimetidine, EDTA (ethylenediaminetetraacetic acid), gabexate, glucagon, iniprol, lexipafant, NSAIDs (non-steroidal anti-inflammatory drugs), octreotide, oxyphenonium, probiotics, activated protein C, somatostatin, somatostatin plus omeprazole, somatostatin plus ulinastatin, thymosin, ulinastatin, and inactive control.